AdvaMed’s Annual Payment Policy Conference brings together device manufacturers, hospitals, insurers, CMS, and Capitol Hill for in-depth discussions and analysis of the reimbursement and coverage landscapes. This event will help you develop new strategies to position your company for success in the fast moving world of medical technology.
The Westin City Center
1400 M St NW, Washington, DC 20005
Room rate: $299
Cut-off date for room reservations: Mar. 22, 2019
Book your group rate for the conference here
AdvaMed Welcome and 2019 Priorities for Medtech Payment and Coverage Policy
Don May, AdvaMed’s Executive Vice President of Payment and Health Care Delivery Policy, will welcome attendees to the conference with an overview of AdvaMed’s 2019 Priorities for payment and health care delivery policy and an environmental scan of issues medtech will face in the year ahead.
Are You Ready for Outcomes Based Contracting?
Medtech companies have been engaging in new ways of contracting and being reimbursed for their innovations – including value or outcomes based contracts that tie payment to improved outcomes, reduced readmissions or infections and broad solutions that wrap around a new technology. These new arrangements require a significant level of due diligence and evidence evaluation to address the level and type of risk that can be shared between manufacturers and providers and plans. What are key strategies for preparing for these arrangements and successfully engaging with the right partners? This session will highlight case examples of successful efforts and the work that lead to these arrangements.
Market Adoption for Digital Health Solutions: Solving the Payment Puzzle
One of the biggest challenges for digital health innovators is answering the question “who will pay?” Traditional device reimbursement models often don’t account for the full value of the solution or the partnerships between patients and providers needed to truly capture value. This panel will explore three key challenges: evidence development through the lens of the financial stakeholder, current reimbursement pathways, including alternative payments and risk sharing models; and finally, the changes in policies affecting market adoption for these solutions.
Showing your Value from the Start: Engaging Payers in your Regulatory Approval Process
FDA’s Ken Skodacek, CDRH’s Deputy Ombudsman (acting), will lead a panel of payers and CMS representatives, along with medtech companies, to discuss efforts to include private payers and CMS in FDA’s regulatory approval process. The session will highlight FDA’s Private Payor Communications Taskforce and the FDA/CMS Parallel Review Program and successes that offer models for medtech companies to combine regulatory and coverage evidence development processes.
Alternative Payment Model Success Stories from Private Payers
While the Center for Medicare and Medicaid Innovation has widely touted alternative payment and delivery models that are being tested to improve quality and lower health spending, private payers have leveraged these models outside of Medicare with great success. This panel will highlight alternative payment models that private payers are using in Medicare Advantage, Medicaid HMOs and employer-based plans.
What’s Up Next on Capitol Hill?
Hear from key Hill staffers from the House and Senate as they discuss key health policy issues and priorities for Republicans and Democrats.
Keynote Speaker Confirmed:
- Charles (Chip) Kahn, III, President & Chief Executive Officer, Federation of American Hospitals
Speakers will include:
- Jay Ahlman, Vice President, Coding and Reimbursement, American Medical Association
- Naomi Aronson, Executive Director of Clinical Evaluation, Innovation and Policy, BlueCross BlueShield Association
- Brett Baker, Senior Health Policy Advisor, Senate Finance Committee
- Daniel Canos – former CMS, FDA
- Sarah Capalla, MS, RN, Director of the Vascular Access Team, Loma Linda University Medical Center
- Greg Corbett, Vice President, National Accounts, Sage Products now part of Stryker
- Melanie Egorin, PhD, Deputy Chief of Staff, Committee on Ways and Means, US House of Representatives
- Richard J. Gentleman, Network Market Head, Aetna
- Cindy Hake, Deputy Director, Division of DMEPOS Policy, Center for Medicare & Medicaid Services
- Myla Maloney, Vice President, Strategic Supplier Engagement, Premier, Inc.
- Shannon Sartin, Executive Director, United States Digital Service
- Ken Skodacek, CDRH Deputy Ombudsman (acting), representing CDRH Innovation and the Payor Communication Task Force, FDA
- Chuck Stemple, Vice President, Health Guidance Organization, Humana
- Laurel Sweeney, Principal, Access Strategies
AdvaMed Accel Member Registration: $695.00
AdvaMed Member Registration: $895.00
Non-Member Registration: $1,195.00
Click here to read the cancellation policy and terms and conditions for this event